CHHE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CHHE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, China Health Industries Holdings's enterprise value is $68.75 Mil. China Health Industries Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.12 Mil. Therefore, China Health Industries Holdings's EV-to-Revenue for today is 587.62.
The historical rank and industry rank for China Health Industries Holdings's EV-to-Revenue or its related term are showing as below:
During the past 13 years, the highest EV-to-Revenue of China Health Industries Holdings was 1801.13. The lowest was -916.25. And the median was -1.19.
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
As of today (2024-05-11), China Health Industries Holdings's stock price is $2.05. China Health Industries Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, China Health Industries Holdings's PS Ratio for today is 1,025.00.
The historical data trend for China Health Industries Holdings's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Industries Holdings Annual Data | |||||||||||||||||||||
Trend | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | |||||||||||
EV-to-Revenue | Get a 7-Day Free Trial | 2.22 | -0.59 | -3.54 | - | 176.50 |
China Health Industries Holdings Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-Revenue | Get a 7-Day Free Trial | -792.91 | -525.77 | 176.50 | 1,345.12 | 321.26 |
For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where China Health Industries Holdings's EV-to-Revenue falls into.
EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.
China Health Industries Holdings's EV-to-Revenue for today is calculated as:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 68.751 | / | 0.117 | |
= | 587.62 |
China Health Industries Holdings's current Enterprise Value is $68.75 Mil.
China Health Industries Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Health Industries Holdings (OTCPK:CHHE) EV-to-Revenue Explanation
The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.
China Health Industries Holdings's PS Ratiofor today is calculated as:
PS Ratio | = | Share Price (Today) | / | Revenue per Share (TTM) |
= | 2.05 | / | 0.002 | |
= | 1,025.00 |
China Health Industries Holdings's share price for today is $2.05.
China Health Industries Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of China Health Industries Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sun Xin | director, 10 percent owner, officer: CEO, CFO and Treasurer | NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000 |
Hall E Ewing | director, officer: Secretary | 2737 W BASELINE RD 22, TEMPE AZ 85283 |
Jack C Robinson | director | 16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297 |
Teri S Foster | director | 402 CANDOVER COURT, KATY TX 77450 |
Brian Lee Hahn | director, officer: COO | 422 LAMONT TERRACE, BUFFALO GROVE IL 60089 |
Dennis Mckee | 10 percent owner | 3522 DOHERTY PLACE, KATY TX 77449 |
Thomas Allen Bontems | 10 percent owner, officer: President, CEO, CFO and, other: Secretary | 1808 S. 1ST AVENUE, PHONEIX AZ 85003 |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.